Our findings strongly suggest that SLC25A1 plays a role for maintenance of the antioxidant defense of lung cancer cells with tolerance to acute or chronic cycling severe hypoxia with potential impact on the sensitivity of the cells to ROS-induced damage. Here, SLC25A1 is linked to lung carcinoma.